Note sull'episodio
What can founders learn from a healthcare workflow that large organizations and independent clinics were both struggling to fix?
In this episode of Startup Builders & Backers, I speak with Charlie Jordan, founder and CEO of VITL, about identifying overlooked customer problems, building technology for legacy markets, and making complicated systems feel simple without weakening trust or compliance.
Charlie’s route into healthcare began during the rapid growth of telehealth in 2020. He later saw compounding pharmacies face a sharp rise in demand, driven in part by direct-to-consumer healthcare and GLP-1 treatments. Fulfillment systems that worked at one volume could quickly develop long backlogs. Prescribers were also entering the same information repeatedly, sending prescriptions into workflows with limited visibility, and spending time chasing pharmacies for updates.
The business opportunity became clearer when Charlie moved from large telehealth organizations to independent practices. The smaller clinics were experiencing the same problems but had far fewer resources available to solve them. If organizations with large budgets and practices with small budgets were both stuck, he reasoned that the workflow itself needed a different answer.
VITL connects cash-pay clinics with verified compounding pharmacies and gives practices a single place to prescribe, compare options, and follow fulfillment. Charlie says the platform has reduced the initial prescribing process from roughly four and a half minutes to 30 seconds. He argues that the larger saving comes after the prescription is written, when status checks, problem resolution, shipment updates, and patient communication would otherwise create hours of additional work.
Speed, however, cannot be separated from responsibility. Compounded medications may carry serious consequences, and Charlie believes the market needs clearer ways to describe and verify quality. He explains how VITL reviews pharmacy standards and ingredients before presenting practices with a network they can use. The aim is to make the experience easier while keeping the checks that protect clinics and patients.
We also discuss Charlie’s design philosophy of beautiful simplicity. His teams ask how little information is needed to complete a task and how few steps a workflow can contain. Repeated data entry is a warning sign. Information collected during patient intake should move through the prescribing process rather than being typed again across several screens.
For founders, Charlie’s most direct lesson concerns uncertainty. Failure is part of building, and no founder will know the answer to every question. The skill is choosing a direction quickly, gathering evidence, and changing course when the decision proves wrong. That lesson becomes especially important in regulated markets, where progress must balance speed with responsibility.
The supplied company brief says VITL works with over 700 clinics and announced a $7.5 million Series A led by SignalFire in March 2026. The scale gives Charlie’s discussion a practical context, but the wider idea applies to any founder facing a market weighed down by old systems and manual work.
Where has your industry accepted unnecessary complexity, and what would it take to redesign that experience around the people doing the work? Listen to the conversation and share your thoughts with me.